weight loss drugs glp-1 for Loss: The Good, Bad and Unknown Understanding Weight Loss Medications: GLP-1

The study shows they prevent new addictions by 14-25% (alcohol, opioids, cocaine, nicotine) AND reduce deaths by 50% in people with existing substance use disorders

Similar to vision concerns, people who say they were impacted by gastroparesis are filing lawsuits against the makers of Ozempic, Mounjaro and other GLP-1 drugs

GDMT for HFrEF typically includes evidence-based beta-blockers, angiotensin receptor neprilysin inhibitors (ARNIs), angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, mineralocorticoid receptor antagonists (MRA), and sodium-glucose cotransporter 2 inhibitors (SGLT2is), particularly in patients with obesity or T2DM [53]

Studies have shown (83) reported that GLP-1R is highly expressed in normal pancreatic secretory cells, expressed at low level in pancreatic acinar cells, not expressed in pancreatic duct cells, and expressed at low or no levels in human pancreatic cancer tissues

If this sounds familiar, its often connected to deeper metabolic factors

J Clin Endocr Metab